The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine
Rasmussen, K, Calligaro, D O, Czachura, J F, Dreshfield-Ahmad, L J, Evans, D C, Hemrick-Luecke, S K, Kallman, M J, Kendrick, W T, Leander, J D, Nelson, D L, Overshiner, C D, Wainscott, D B, Wolff, M C, Wong, D T, Branchek, T A, Zgombick, J M, Xu, Y C
Published in The Journal of pharmacology and experimental therapeutics (01.08.2000)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.08.2000)
Journal Article
The Novel 5-Hydroxytryptamine1A Antagonist LY426965: Effects on Nicotine Withdrawal and Interactions with Fluoxetine
Kurt Rasmussen, David O. Calligaro, Janet F. Czachura, Laura J. Dreshfield-Ahmad, David C. Evans, Susan K. Hemrick-Luecke, Mary Jeanne Kallman, William T. Kendrick, J. David Leander, David L. Nelson, Carl D. Overshiner, David B. Wainscott, Mary C. Wolff, David T. Wong, Theresa A. Branchek, John M. Zgombick, Yao-chang Xu
Published in The Journal of pharmacology and experimental therapeutics (01.08.2000)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.08.2000)
Journal Article
Pharmacological profile of LY301317, a potent and selective 5-HT1A agonist
Wolff, Mary C., Benvenga, Mark J., Calligaro, David O., Fuller, Ray W., Gidda, Jaswant S., Hemrick-Luecke, Susan, Lucot, James B., Nelson, David L., Overshiner, Carl D., Leander, J. David
Published in Drug development research (01.01.1997)
Published in Drug development research (01.01.1997)
Get full text
Journal Article